Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Endo, Ibaraki
Akito Endo, Ibaraki JP
| Patent application number | Description | Published |
|---|---|---|
| 20100302319 | PATTERN DRAWING METHOD AND PATTERN DRAWING APPARATUS - Disclosed herein is a fine and thick wiring drawn at high speed in such a manner that a region on the substrate, on which region the liquid droplet is scheduled to impact, is heated beforehand, and that immediately after the impact of the liquid droplet on the substrate, the liquid droplet is promptly solidified so as thereby to suppress the spread of the liquid droplet due to the wettability of the liquid droplet to the substrate, and also to suppress the clogging of the nozzle due to the heating of the substrate. Thereby, even in the case where a liquid droplet having a larger volume than before is used, high-speed drawing of a thick and fine wiring having a line width approximately equal to the liquid droplet size is realized independently of the substrate material. | 12-02-2010 |
Katsuya Endo, Ibaraki JP
| Patent application number | Description | Published |
|---|---|---|
| 20090311684 | ENHANCED FC RECEPTOR-MEDIATED TUMOR NECROSIS FACTOR SUPERFAMILY AND CHEMOKINE MRNA EXPRESSION IN PERIPHERAL BLOOD LEUKOCYTES IN PATIENTS WITH RHEUMATOID ARTHRITIS - A method for predicting patient responsiveness to rheumatoid arthritis treatments involving altering expression of TNFSF-3, TNFSF-4, TNFSF-7, TNFSF-11, or TNFSF-14 is disclosed. A method for monitoring the effectiveness of such therapy is also disclosed. Furthermore, a method of screening compounds for use in the treatment of rheumatoid arthritis is disclosed. A method of monitoring the disease state over time in rheumatoid arthritis patients is also disclosed. | 12-17-2009 |
| 20100279296 | ENHANCED FC RECEPTOR-MEDIATED TUMOR NECROSIS FACTOR SUPERFAMILY MRNA EXPRESSION IN PERIPHERAL BLOOD LEUKOCYTES IN PATIENTS WITH RHEUMATOID ARTHRITIS - A method for predicting patient responsiveness to rheumatoid arthritis treatments involving altering expression of tumor necrosis factor superfamily (“TNFSF”)-2, TNFSF-8, or TNFSF-15 is disclosed. A method for monitoring the effectiveness of such therapy is also disclosed. Furthermore, a method of screening compounds for use in the treatment of rheumatoid arthritis is disclosed. A method of monitoring the disease state over time in rheumatoid arthritis patients is also disclosed. | 11-04-2010 |
Kazuhiko Endo, Ibaraki JP
| Patent application number | Description | Published |
|---|---|---|
| 20090014881 | SEMICONDUCTOR DEVICE, AND METHOD AND APPARATUS FOR MANUFACTURING SAME - For the purpose of removing an oxide film on the surface of a varying metal electroconductive material used for wiring in a semiconductor device without inflicting damage on a peripheral structure, the oxide film formed on the surface of a metal electroconductive region | 01-15-2009 |
| 20100213546 | FIELD-EFFECT TRANSISTOR AND INTEGRATED CIRCUIT INCLUDING THE SAME - A field-effect transistor comprising a movable gate electrode that suppresses a leakage current from the gate electrode, and has a large current drivability and a low leakage current between a source and a drain. The field-effect transistor comprises: an insulating substrate; a semiconductor layer of triangle cross-sectional shape formed on the insulating substrate, having a gate insulation film on a surface, and forming a channel in a lateral direction; fixed electrodes that are arranged adjacent to both sides of the semiconductor layer and in parallel to the semiconductor layer, each of the electrodes having an insulation film on a surface; a source/drain formed at the end part of the semiconductor layer; and the movable gate electrode formed above the semiconductor layer and the fixed electrodes with a gap. | 08-26-2010 |
| 20100315861 | SRAM CELL AND SRAM DEVICE - In an SRAM cell including a first to a fourth semiconductor thin plates which stand on a substrate and are arranged in parallel to each other, on each of the four semiconductor thin plates being formed a first four-terminal double-gate FET with a first conductivity type; a second and a third four-terminal double-gate FETs which are connected in series with each other and have a second conductivity type; a fourth and a fifth four-terminal double-gate FETs which are connected in series with each other and have the second conductivity type; a sixth four-terminal double-gate FET with the first conductivity type, wherein the third and the fourth four-terminal double-gate FETs form select transistors, and the first, the second, the fifth and the sixth four-terminal double-gate FETs form a CMOS inverter, logic signal input gates of the first and the sixth four-terminal double-gate FETs are arranged on the side facing the second and the third semiconductor thin plates, respectively, while threshold voltage control gates of the second to the fifth four-terminal double-gate FETs are arranged on the sides facing each other and are commonly connected to a first bias line. Threshold voltage control gates of the first and the sixth four-terminal double-gate FETs are commonly connected to a second bias line. A word line, the first bias line and the second bias line are arranged orthogonally to the direction of arrangement of the first to the fourth semiconductor thin plates. | 12-16-2010 |
| 20100328990 | SRAM DEVICE - An SRAM device comprising a memory cell, the memory cell comprising two access transistors connected to a word line, and a flip-flop circuit having complementary transistors, the transistor being a field effect transistor having a standing semiconductor thin plate, a logic signal input gate and a bias voltage input gate, the gates sandwiching the semiconductor thin plate and being electrically separated from each other, and | 12-30-2010 |
Ko-Suke Endo, Ibaraki JP
| Patent application number | Description | Published |
|---|---|---|
| 20100152419 | FUSION PROTEIN CONTAINING HIGHLY-EXPRESSED AND SECRETED INSULIN PRECURSOR, DNA ENCODING SAME, AND METHOD OF PRODUCING INSULIN - A DNA which encodes a fused protein containing an insulin precursor of the overexpression secretion type for producing transgenic insulin, and a method of producing insulin with the use of this DNA. | 06-17-2010 |
Ryosai Endo, Ibaraki JP
| Patent application number | Description | Published |
|---|---|---|
| 20110243817 | Zirconium Crucible - Provided is a zirconium crucible for analytical use, wherein the purity excluding gas components is 3N or higher and the content of oxygen as a gas component is 500 mass ppm or less. In light of the recent analytical technology for which a fast and accurate measurement of high-purity materials is required; an object of the present invention is to inhibit the incorporation of impurities from a crucible by using a high-purity crucible, and provide a zirconium crucible for analytical use, wherein a two-stage separation/decomposition process is not required in the analysis of samples in which various types of oxides and metals such as sludge, bottom sediment samples and soil coexist, and the number of times that the crucible can be used is increased by improving the durability of high-purity zirconium metal. | 10-06-2011 |
Ryuichi Endo, Ibaraki JP
| Patent application number | Description | Published |
|---|---|---|
| 20100047131 | TESTING DEVICE - A testing device is provided which is able to distribute a liquid sample to a plurality of reaction sections by a simple operation without using a tip dispenser, and also achieves individually independent reaction systems without causing reaction sections to be in communication with each other due to a liquid sample. The testing device has a transparent molded body which includes: a storage chamber for injecting/holding a liquid sample; a reaction chamber for causing a reaction of the sample; a receiving chamber for sucking and receiving the sample, with the storage chamber and the reaction chamber being in communication with each other via a distributing flow path, and the reaction chamber and the receiving chamber being in communication with each other via a sucking flow path; and a liquid reservoir between the reaction chamber and the receiving chamber. | 02-25-2010 |
Tatsuki Endo, Ibaraki JP
| Patent application number | Description | Published |
|---|---|---|
| 20100181083 | FIRE-EXTINGUISHING SPRAY NOZZLE AND FIRE-EXTINGUISHING EQUIPMENT - Low-pressure fire-extinguishing liquid is converted into mist. A fire-extinguishing spray nozzle ( | 07-22-2010 |
| 20100224377 | FIRE-EXTINGUSHING SPRAY NOZZLE AND FIRE-EXTINGUISHING EQUIPMENT - Low-pressure fire-extinguishing liquid is converted into mist. A fire-extinguishing spray nozzle ( | 09-09-2010 |
Tsuyoshi Endo, Ibaraki JP
| Patent application number | Description | Published |
|---|---|---|
| 20080226697 | Patch for External Use with Elevated Content of Absorption Promoter in Pressure-Sensitive Adhesive Base - A pressure-sensitive adhesive composition for transdermal absorption which contains a drug and a transdermal absorption promoter for the drug, characterized by further containing polyvinylpyrrolidone so as to stabilize the transdermal absorption promoter contained in the adhesive composition. Thus, the transdermal absorption promoter can be prevented from vaporization or degradation and a patch for external use containing the transdermal absorption promoter at a high concentration in using can be provided. | 09-18-2008 |